Posts Tagged 'abbvie'

Androgel Manufacturer Drops Plan to Purchase Shire

First Word Pharma reports that Androgel maker AbbVie has abandoned its plan to buy out pharmaceutical maker Shire. AbbVie says the bid for Shire was withdrawn in light of recent U.S. tax law changes. As a result of the failed deal, AbbVie will have to pay $1.6 billion to Shire and will be unable to make another offer to purchase the company for at least a year.

The Androgel maker was recently in the news over ...

continue reading...
Page 3 of 3 123